Arletti R, Benelli A, Bertolini A
Institute of Pharmacology, University of Modena, Italy.
Peptides. 1989 Jan-Feb;10(1):89-93. doi: 10.1016/0196-9781(89)90082-x.
Oxytocin, whether administered intraperitoneally (IP) (375-6,000 micrograms/kg) or intracerebroventricularly (ICV) (1-10 micrograms/rat), dose-dependently reduced food consumption and time spent eating and increased the latency to the first meal in rats fasted for 21 hr. Pretreatment with the oxytocin antagonist d(CH2)5Tyr(Me)-[Orn8]vasotocin (ICV 10 micrograms/rat) completely prevented the feeding inhibitory effect of an equal dose of ICV oxytocin, and per se increased food intake. Our data further support the hypothesis that oxytocin plays the role of neurotransmitter or neuromodulator in the CNS, and suggest that its involvement in a number of homeostatic systems may include appetite control.
催产素,无论是腹腔注射(IP)(375 - 6000微克/千克)还是脑室内注射(ICV)(1 - 10微克/只大鼠),均呈剂量依赖性地减少禁食21小时大鼠的食物摄入量和进食时间,并延长首次进食的潜伏期。用催产素拮抗剂d(CH2)5Tyr(Me)-[Orn8]血管紧张素(ICV 10微克/只大鼠)预处理可完全阻断等量ICV催产素的摄食抑制作用,且其本身会增加食物摄入量。我们的数据进一步支持了催产素在中枢神经系统中作为神经递质或神经调节剂发挥作用的假说,并表明其参与多个稳态系统可能包括食欲控制。